top of page

Feel Therapeutics highlighted in IQVIA's 2022 ESG Report



IQVIA’s commitment to sustainability

IQVIA is the leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Propelled by the mission to drive healthcare forward, IQVIA aims to deliver better patient outcomes through innovation, technology and the advancement of medical treatments. In addition to accelerating innovation in healthcare, IQVIA is driven by a strong commitment to sustainability. The company consistently identifies and takes action on environmental, social, and governance (ESG) issues.


Feel Therapeutics part of the IQVIA’s Innovation Hub.

Feel Therapeutics was highlighted In IQVIA's recently published 2022 ESG Report, as one of the promising startups identified in the IQVIA Innovation Hub. The Hub invests in and forms strategic partnerships with tech start-ups, providing access to the extensive IQVIA network of assets, resources, clients, and partners. The Hub’s goal is to accelerate clinical development, enhance commercialization efforts, and drive the implementation of digital health solutions, such as biomarkers. In the case of biomarkers, these can be used for improved patient outcomes and engagement, and support the reduction of clinical trial carbon footprint.


In 2022, the Hub launched the IQVIA Accelerator Program – a seven-week course designed to accelerate the growth of early-stage healthcare start-ups into the healthcare market. Feel Therapeutics was one of the eight applicants that were accepted. We are excited to collaborate with IQVIA and proud to be highlighted in their report!


Read IQVIA’s ESG report here.


תגובות


bottom of page